Autologous adipose-derived mesenchymal stem cell therapy(Assistance Publique - Hopitaux De Marseille)

自体脂肪来源的间充质干细胞疗法（Assistance Publique - Hopitaux De Marseille）

Report date: 2023/05/17 20:00:39

Base Information

Drug NameAutologous adipose-derived mesenchymal stem cell therapy(Assistance Publique - Hopitaux De Marseille)

Drug Alias Nameautologous adult stem cell therapy(Assistance Publique - Hopitaux De Marseille)

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsXerostomia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAssistance Publique - Hopitaux De Marseille

China Registration ClassN/A

Develop Information

Active CompaniesAssistance Publique - Hopitaux De Marseille

Inactive CompaniesN/A

Active IndicationsXerostomia

Inactive IndicationsN/A

Other Information

ATC CodeN/A